With one of the lowest survival rates of all cancers, pancreatic cancer developments are generally big news. Such is the case for a recent study that shows a new, experimental drug may provide a glimmer of hope to patients when it is combined with use of a long-standing cancer-fighting agent. While still very much in…

With nearly 50,000 new cases of pancreatic cancer reported yearly in the United States and some 40,000 deaths, the race to find better treatments for the disease is well under way. Even so, researchers have been plagued in their efforts to improve outcome for patients diagnosed with this form of cancer. With a 10-year survival…